2rounds
—led
AI 1Climate tech 1
Series A 1, Series B 1
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Neurophos $110M Series ASage Geosystems $97M Series BLoading investors…
Loading investors…
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 5, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Neurophos $110M Series ASage Geosystems $97M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Neurophos $110M Series AQuadric $30M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Neurophos $110M Series APluto Financial Technologies $8.6M SeedNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Shield Space £2M UndisclosedWholeSum £730K Pre-SeedNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Preply $150M Series DHOLYWATER $22M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Fracttal $35M UndisclosedTucuvi $20M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Exciva €51M Series BSpiro Medical $67M Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Exciva €51M Series BKinaset Therapeutics $103M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Orbem €55.5M Series BTransition Metal Solutions $6M SeedNew companies 2 · Follow-on 0
Stages: Series A 2
Think Bioscience $55M Series AVivere Oncotherapies $10M Series ANew companies 2 · Follow-on 0
Stages: Undisclosed 2
StarLIMS Undisclosed UndisclosedAvalon Healthcare Solutions Undisclosed UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Converge Bio $25M Series ABiographica £7M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Mirador Therapeutics $250M Series BParabilis Medicines $305M Series FNew companies 2 · Follow-on 0
Stages: Series A 2
Vibrant Therapeutics $61M Series ASpiro Medical $67M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
VieCure $43M UndisclosedVizgen $48M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Ventaris Surgical $30M Series AAirNexis Therapeutics $200M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Enodia Therapeutics €20.7M SeedEpiBiologics $107M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.